Although there are no human studies in both ICH and ischemic stroke, an experimental study in rats shows how gene therapy with hepatocyte growth factor improved significantly learning and memory during the recovery phase of stroke related to an increase of CDC42 positive pyramidal neurons in the periinfarct areas and enhanced neuritogenesis [41]. Here, CDC42 is linked to Stroke.